C9orf72 repeat transcripts undergo non-ATG translation producing DPRs (poly-GA, poly-GR, poly-PR) that sequester nucleocytoplasmic transport factors (RanGAP1, NUP205, TPR), causing nuclear envelope rupture and transport impairment. This represents the most mechanistically detailed hypothesis for C9orf72-ALS/FTD, with compelling evidence from multiple laboratories and promising therapeutic candidates (KPT-276, importin-β agonists). However, causality remains debated—DPR accumulation may be a cons
## Mechanistic Overview
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration starts from the claim that modulating TREM2 within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "## **Molecular Mechanism and Rationale** The TREM2 (Triggering Receptor Expressed on Myeloid cells 2) signaling cascade represents a critical node in neuroinflammation regulation, with its dysfunction fundamentally altering astrocyte-microgli
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
No evidence citations yet
Debate Excerpts
C9orf72 Hexanucleotide Repeat Dipeptide Repeat Pro
4 rounds · quality: 0.81
Theorist
# Legacy Pre-Pipeline Hypotheses: Neurodegeneration
---
## Hypothesis 1: Exosomal α-Synuclein as an Interneuronal Propagation Vector in Parkinson's Disease
**Mechanism:** Misfolded α-synuclein (aSy...
Skeptic
# Critical Evaluation of Legacy Pre-Pipeline Hypotheses
## General Methodological Concerns (Cross-Cutting Issues)
Before evaluating individual hypotheses, several systemic weaknesses affect the enti...
Domain Expert
# Comprehensive Feasibility Assessment: Legacy Neurodegeneration Hypotheses
## Preamble
This assessment evaluates each hypothesis across five critical domains using a standardized framework. Evidenc...
Synthesizer
```json
{
"ranked_hypotheses": [
{
"title": "TREM2-Deficient Microglia as Drivers of Amyloid Plaque Toxicity in Alzheimer's Disease",
"description": "TREM2 loss-of-function variants ...
TREM2-Dependent Astrocyte-Microglia Cross-talk in
4 rounds · quality: 0.92
Theorist
Based on the provided literature, TREM2 is a microglial surface receptor governing the disease-associated microglia (DAM) program. The TREM2 R47H loss-of-function variant increases Alzheimer's risk ~3...
Skeptic
The INVOKE-2 trial (AL002, TREM2 agonist) failed to meet primary endpoints in 2024. This raises questions about mechanism appropriateness, off-target effects from systemic activation, and whether amyl...
Domain Expert
TREM2 biology is highly stage-dependent. In early AD, TREM2 activation promotes amyloid clearance via DAM. In late AD, DAM may become senescent and contribute to chronic inflammation. Biomarker guidan...
Synthesizer
## TREM2 Showcase Synthesis
**Core verdict:** TREM2 is a legitimate but timing-sensitive AD target requiring biomarker-guided, stage-specific therapeutic modulation.
**Mechanistic consensus:** TREM2...